Jaime Gállego Pérez‐Larraya

3.7k total citations · 2 hit papers
48 papers, 1.5k citations indexed

About

Jaime Gállego Pérez‐Larraya is a scholar working on Genetics, Molecular Biology and Neurology. According to data from OpenAlex, Jaime Gállego Pérez‐Larraya has authored 48 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Genetics, 12 papers in Molecular Biology and 12 papers in Neurology. Recurrent topics in Jaime Gállego Pérez‐Larraya's work include Glioma Diagnosis and Treatment (22 papers), Brain Metastases and Treatment (9 papers) and Meningioma and schwannoma management (7 papers). Jaime Gállego Pérez‐Larraya is often cited by papers focused on Glioma Diagnosis and Treatment (22 papers), Brain Metastases and Treatment (9 papers) and Meningioma and schwannoma management (7 papers). Jaime Gállego Pérez‐Larraya collaborates with scholars based in Spain, France and United States. Jaime Gállego Pérez‐Larraya's co-authors include Jean‐Yves Delattre, Sonia Tejada, Miguel Á. Idoate, Susana Inogés, Jerzy Hildebrand, Ricardo Díez-Valle, Ascensión López-Dı́az de Cerio, José Luis Perez‐Gracia, Marc Sanson and Carlos de Andrea and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jaime Gállego Pérez‐Larraya

47 papers receiving 1.5k citations

Hit Papers

Neoadjuvant nivolumab modifies the tumor immune microenvi... 2019 2026 2021 2023 2019 2024 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
    2019 449 citations Kurt A. Schalper, María E. Rodríguez-Ruiz et al. Nature Medicine profile →
  2. Dendritic Cells in Cancer Immunology and Immunotherapy
    2024 62 citations José Luis Perez‐Gracia, Javier Rodríguez et al. Cancers profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jaime Gállego Pérez‐Larraya Spain 18 861 536 409 408 354 48 1.5k
Ricardo Díez-Valle Spain 15 706 0.8× 432 0.8× 196 0.5× 283 0.7× 333 0.9× 27 1.2k
Sonia Tejada Spain 15 822 1.0× 442 0.8× 228 0.6× 357 0.9× 185 0.5× 34 1.2k
Tiffany R. Hodges United States 19 722 0.8× 280 0.5× 289 0.7× 184 0.5× 316 0.9× 43 1.5k
Véronique Quillien France 27 893 1.0× 665 1.2× 325 0.8× 609 1.5× 1.0k 2.9× 71 2.2k
Matthew M. Grabowski United States 14 683 0.8× 276 0.5× 244 0.6× 378 0.9× 177 0.5× 36 1.1k
Eugene Hwang United States 19 635 0.7× 323 0.6× 197 0.5× 230 0.6× 398 1.1× 57 1.2k
Pei Yang China 22 613 0.7× 281 0.5× 322 0.8× 194 0.5× 530 1.5× 46 1.3k
Yuanxuan Xia United States 12 515 0.6× 402 0.8× 229 0.6× 492 1.2× 436 1.2× 43 1.4k
Masahide Matsuda Japan 21 622 0.7× 228 0.4× 235 0.6× 186 0.5× 218 0.6× 110 1.3k
Koichi Mitsuya Japan 22 461 0.5× 650 1.2× 577 1.4× 254 0.6× 241 0.7× 84 1.4k

Countries citing papers authored by Jaime Gállego Pérez‐Larraya

Since Specialization
Citations

This map shows the geographic impact of Jaime Gállego Pérez‐Larraya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaime Gállego Pérez‐Larraya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaime Gállego Pérez‐Larraya more than expected).

Fields of papers citing papers by Jaime Gállego Pérez‐Larraya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaime Gállego Pérez‐Larraya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaime Gállego Pérez‐Larraya. The network helps show where Jaime Gállego Pérez‐Larraya may publish in the future.

Co-authorship network of co-authors of Jaime Gállego Pérez‐Larraya

This figure shows the co-authorship network connecting the top 25 collaborators of Jaime Gállego Pérez‐Larraya. A scholar is included among the top collaborators of Jaime Gállego Pérez‐Larraya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaime Gállego Pérez‐Larraya. Jaime Gállego Pérez‐Larraya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perez‐Gracia, José Luis, Javier Rodríguez, Jaime Gállego Pérez‐Larraya, et al.. (2024). Dendritic Cells in Cancer Immunology and Immunotherapy. Cancers. 16(5). 981–981. 62 indexed citations breakdown →
2.
Pérez‐Larraya, Jaime Gállego, Marc García-Moure, & Marta M. Alonso. (2023). Oncolytic virotherapy for the treatment of pediatric brainstem gliomas. Revue Neurologique. 179(5). 475–480. 1 indexed citations
3.
Moreno‐Ajona, David, et al.. (2020). 18F-FDG-PET Imaging Patterns in Autoimmune Encephalitis: Impact of Image Analysis on the Results. Diagnostics. 10(6). 356–356. 34 indexed citations
4.
Puigdelloses, Montse, Marisol González-Huarriz, Marc García-Moure, et al.. (2020). RNU6-1 in circulating exosomes differentiates GBM from non-neoplastic brain lesions and PCNSL but not from brain metastases. Neuro-Oncology Advances. 2(1). vdaa010–vdaa010. 14 indexed citations
5.
Schalper, Kurt A., María E. Rodríguez-Ruiz, Ricardo Díez-Valle, et al.. (2019). Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma. Nature Medicine. 25(3). 470–476. 449 indexed citations breakdown →
6.
Pérez‐Larraya, Jaime Gállego, et al.. (2019). Encefalitis límbica asociada a anti-Caspr2: contribución del análisis visual ayudado de las imágenes PET con 18F-FDG mediante comparación con una base de datos de normalidad. Revista Española de Medicina Nuclear e Imagen Molecular. 39(2). 92–95. 2 indexed citations
7.
Moreno‐Ajona, David, José Ramón Yuste, Paloma Leticia Martín-Moreno, & Jaime Gállego Pérez‐Larraya. (2018). HTLV-1 myelopathy after renal transplant and antiviral prophylaxis: the need for screening. Journal of NeuroVirology. 24(4). 523–525. 10 indexed citations
8.
Díez-Valle, Ricardo, et al.. (2018). Management of diffuse glioma. La Presse Médicale. 47(11-12). e199–e212. 13 indexed citations
9.
Inogés, Susana, Sonia Tejada, Ascensión López-Dı́az de Cerio, et al.. (2017). A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients. Journal of Translational Medicine. 15(1). 104–104. 109 indexed citations
10.
Arbizu, Javier, Alessandro Giuliani, Jaime Gállego Pérez‐Larraya, et al.. (2017). Emerging clinical issues and multivariate analyses in PET investigations. The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 61(4). 386–404. 5 indexed citations
11.
Cayuela, Núria, Marta Simó, Carles Majós, et al.. (2017). Seizure‐susceptible brain regions in glioblastoma: identification of patients at risk. European Journal of Neurology. 25(2). 387–394. 14 indexed citations
12.
Tejada, Sonia, et al.. (2016). ACTR-15. A PHASE I STUDY OF THE ONCOLYTIC VIRUS DNX-2401 AND A SHORT COURSE TEMOZOLOMIDE FOR GLIOBLASTOMA AT FIRST RECURRENCE. Neuro-Oncology. 18(suppl_6). vi4–vi4. 3 indexed citations
13.
Ortega‐Cubero, Sara, M. R. Luquín, C. Viteri, et al.. (2014). Descripción de una serie de pacientes con diagnóstico de enfermedad priónica. Neurología. 30(3). 144–152. 7 indexed citations
14.
Boisselier, Blandine, Jaime Gállego Pérez‐Larraya, Marta Rossetto, et al.. (2012). Detection of IDH1 mutation in the plasma of patients with glioma. Neurology. 79(16). 1693–1698. 92 indexed citations
15.
Palma, Jose‐Alberto, et al.. (2012). Leptomeningeal carcinomatosis: Prognostic value of clinical, cerebrospinal fluid, and neuroimaging features. Clinical Neurology and Neurosurgery. 115(1). 19–25. 30 indexed citations
16.
Pérez‐Larraya, Jaime Gállego & Jean-Yves Delattre. (2012). Treating glioblastoma in the elderly. CNS Oncology. 1(2). 193–201. 3 indexed citations
17.
Pérez‐Larraya, Jaime Gállego, Pablo Irimia, Eduardo Martínez‐Vila, et al.. (2012). The influence of obesity on the assessment of carotid intima‐media thickness. Journal of Clinical Ultrasound. 40(8). 479–485. 9 indexed citations
18.
Pérez‐Larraya, Jaime Gállego, François Ducray, Olivier Chinot, et al.. (2011). Temozolomide in Elderly Patients With Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial. Journal of Clinical Oncology. 29(22). 3050–3055. 160 indexed citations
19.
Pérez‐Larraya, Jaime Gállego & Mario Riverol. (2009). Facial Diplegia and Vestibular Neuritis Secondary to HIV Seroconversion Syndrome. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 36(4). 527–528. 4 indexed citations
20.
Pérez‐Larraya, Jaime Gállego, Jon B. Toledo, Elena Urrestarazu, & J. Iriarte. (2007). Clasificación de los trastornos del sueño. Anales del Sistema Sanitario de Navarra. 30. 19–36. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ricardo Díez-Valle Breakdown of academic impact, for papers by Sonia Tejada Breakdown of academic impact, for papers by Tiffany R. Hodges Breakdown of academic impact, for papers by Véronique Quillien Breakdown of academic impact, for papers by Matthew M. Grabowski Breakdown of academic impact, for papers by Eugene Hwang Breakdown of academic impact, for papers by Pei Yang Breakdown of academic impact, for papers by Yuanxuan Xia Breakdown of academic impact, for papers by Masahide Matsuda Breakdown of academic impact, for papers by Koichi Mitsuya
Rankless by CCL
2026